Generic Drug Pricing Fraud
Generic drug pricing fraud occurs when pharmaceutical manufacturers illegally collude to fix prices or pay kickbacks to inflate generic drug costs paid by Medicare and Medicaid. These schemes cost taxpayers billions and undermine fair competition. Teva Pharmaceuticals, the largest U.S. generic drug manufacturer, agreed to pay $450 million in 2024 to resolve False Claims Act










